Resultados de procura - Richard Nichols

Limitar resultados
  1. 1
    A Three Dimensional Model of the Feline Hindlimb

    A Three Dimensional Model of the Feline Hindlimb por Burkholder, Thomas J., Richard Nichols, T.

    Publicado 2004
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  2. 2
    Electromyographic Responses From the Hindlimb Muscles of the Decerebrate Cat to Horizontal Support Surface Perturbations

    Electromyographic Responses From the Hindlimb Muscles of the Decerebrate Cat to Horizontal Support Surface Perturbations por Claire F. Honeycutt, Jinger S. Gottschall, T. Richard Nichols

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    8 Rapid Spinal Mechanisms of Motor Coordination

    8 Rapid Spinal Mechanisms of Motor Coordination por T. Richard Nichols, Timothy C. Cope, Thomas A. Abelew

    Publicado 1999
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    The effects of self-reinnervation of cat medial and lateral gastrocnemius muscles on hindlimb kinematics in slope walking

    The effects of self-reinnervation of cat medial and lateral gastrocnemius muscles on hindlimb kinematics in slope walking por Huub Maas, Boris I. Prilutsky, T. Richard Nichols, Robert J. Gregor

    Publicado 2007
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Principles Underlying New Methods for Chronic Neural Recording

    Principles Underlying New Methods for Chronic Neural Recording por R. B. Stein, Dean Charles, LYLE A. DAVIS, Jack H. Jhamandas, Allan Mannard, T. Richard Nichols

    Publicado 1975
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge

    Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge por Kathleen A. Marriott, Christopher V. Parkinson, Samantha I. Morefield, Robert Davenport, Richard Nichols, Thomas P. Monath

    Publicado 2007
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Yellow Fever 17D Vaccine Safety and Immunogenicity in the Elderly

    Yellow Fever 17D Vaccine Safety and Immunogenicity in the Elderly por Thomas P. Monath, Martín S. Cetron, Karen McCarthy, Richard Nichols, W. Tad Archambault, Leisa Weld, Philip Bedford

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Safety and Immunogenicity of Increasing Doses of a <i>Clostridium difficile</i> Toxoid Vaccine Administered to Healthy Adults

    Safety and Immunogenicity of Increasing Doses of a <i>Clostridium difficile</i> Toxoid Vaccine Administered to Healthy Adults por Karen L. Kotloff, Steven S. Wasserman, Genevieve A. Losonsky, William D. Thomas, Richard Nichols, Robert Edelman, Margaret W. Bridwell, Thomas P. Monath

    Publicado 2001
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Immunization of Mice with Urease Vaccine Affords Protection against <i>Helicobacter pylori</i> Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted Responses

    Immunization of Mice with Urease Vaccine Affords Protection against <i>Helicobacter pylori</i> Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted Res... por Thomas H. Ermak, Paul J. Giannasca, Richard Nichols, Gwendolyn A. Myers, John G. Nedrud, Richard Weltzin, Cynthia Lee, Harold Kleanthous, Thomas P. Monath

    Publicado 1998
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

    Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial. por Thomas P. Monath, Richard Nichols, W. Tad Archambault, Linda W. Moore, Ron Marchesani, Jason Tian, Robert E. Shope, Nicola Thomas, Robert Schrader, Dean Furby, Philip Bedford

    Publicado 2002
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys

    Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys por Thomas P. Monath, Inessa S. Levenbook, Kenneth F. Soike, Z.-X. Zhang, Marion S. Ratterree, Ken Draper, Alan D.T. Barrett, Richard Nichols, Richard Weltzin, Juan Arroyo, Farshad Guirakhoo

    Publicado 2000
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults

    Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults por Scott A. Halperin, Rituparna Das, Matthew Onorato, Kenneth Liu, Jason Martin, Rebecca J. Grant-Klein, Richard Nichols, Beth-Ann Coller, F.A. Helmond, Jakub K. Simon

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defense

    ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defense por Thomas P. Monath, Joseph R. Caldwell, Wolfgang Mundt, Joan Fusco, Casey Johnson, Mark Buller, Jian Liu, Bridget Gardner, Greg Downing, Paul S. Blum, Tracy Kemp, Richard Nichols, Richard Weltzin

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines

    One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines por Heiko Ilchmann, Nathaly Samy, Daniela Reichhardt, Darja Schmidt, Jacqueline D Powell, Thomas P.H. Meyer, Günter Silbernagl, Richard Nichols, Heinz Weidenthaler, Laurence De Moerlooze, Liddy Chen, Paul Chaplin

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Rectal and Intranasal Immunizations with Recombinant Urease Induce Distinct Local and Serum Immune Responses in Mice and Protect against <i>Helicobacter pylori</i> Infection

    Rectal and Intranasal Immunizations with Recombinant Urease Induce Distinct Local and Serum Immune Responses in Mice and Protect against <i>Helicobacter pylori</i> Infection por Harry Kleanthous, Gwendolyn A. Myers, K. Georgakopoulos, Timothy Tibbitts, Jennifer W. Ingrassia, Heather Gray, Ru Ding, Zhen-Zi Zhang, Wen-de Lei, Richard Nichols, Cynthia Lee, Thomas H. Ermak, Thomas P. Monath

    Publicado 1998
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis

    A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Derma... por Richard N. Greenberg, Yadira Hurley, Dinh V. Dinh, Serena Mraz, Javier Gómez Vera, Dorothea von Bredow, Alfred von Krempelhuber, Siegfried Röesch, Garth Virgin, Nathaly Arndtz-Wiedemann, Thomas Meyer, Darja Schmidt, Richard Nichols, Philip Young, Paul Chaplin

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment

    rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/be... por Thomas P. Monath, Patricia Fast, Kayvon Modjarrad, David K. Clarke, Brian K. Martin, Joan Fusco, Richard Nichols, D. Gray Heppner, Jakub K. Simon, Sheri Dubey, Sean P. Troth, Jayanthi Wolf, Vidisha Singh, Beth-Ann Coller, James S. Robertson

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults

    Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults por Pierre Michetti, Christianna Kreiss, Karen L. Kotloff, Nadine Porta, J Blanco, Daniel Bachmann, Maribelle Herranz, Pierre F. Saldinger, Irène Corthésy–Theulaz, Genevieve A. Losonsky, Richard Nichols, Joseph Simon, Manfred Stolte, Samuel Ackerman, Thomas P. Monath, A. L. Blum

    Publicado 1999
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    A live, attenuated recombinant West Nile virus vaccine

    A live, attenuated recombinant West Nile virus vaccine por Thomas P. Monath, Jian Liu, Niranjan Kanesa-thasan, Gwendolyn A. Myers, Richard Nichols, Alison Deary, Karen McCarthy, Casey Johnson, Thomas H. Ermak, Sunheang Shin, Juan Arroyo, Farshad Guirakhoo, Jeffrey S. Kennedy, Francis A. Ennis, Sharone Green, Philip Bedford

    Publicado 2006
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects

    A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old S... por Richard N. Greenberg, Christine M. Hay, Jack T. Stapleton, Thomas Marbury, Eva Wagner, Eva Kreitmeir, Siegfried Röesch, Alfred von Krempelhuber, Philip Young, Richard Nichols, Thomas P.H. Meyer, Darja Schmidt, Josef Weigl, Garth Virgin, Nathaly Arndtz-Wiedemann, Paul Chaplin

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: